Stay updated on Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added Study Protocol and Statistical Analysis Plan content and related metadata to the Study Documents section. Removed a 500 error page placeholder to restore normal page content.
    Difference
    87%
    Check dated 2026-08-16T01:47:36.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision tag on the page was updated from v3.6.4 to v3.6.5, reflecting a new build of the ClinicalTrials.gov interface. This change is a minor UI/backend update and does not modify study data or visible content on the page.
    Difference
    0.0%
    Check dated 2026-08-08T23:50:05.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision label updated to v3.6.4 on the page, representing a version update in the page template without altering study details. No content changes to the study information are introduced.
    Difference
    0.0%
    Check dated 2026-07-25T12:47:01.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.2 to v3.6.3, indicating a minor documentation/version update.
    Difference
    0.0%
    Check dated 2026-07-03T23:23:54.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.6.2 was added and v3.6.0 was removed. This indicates a page update or maintenance rather than any new or altered study details.
    Difference
    0.0%
    Check dated 2026-06-26T23:55:03.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    New help/navigation sections were added: How to Read a Study Record, Common Questions, and How to Join a Study. A recruitment status note indicates enrollment is closed ('No longer looking for participants'), and a site revision (Revision: v3.6.0) was added.
    Difference
    0.3%
    Check dated 2026-06-12T16:13:55.000Z thumbnail image

Stay in the know with updates to Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab±Anetumab in Mesothelin+ Pleural Mesothelioma Clinical Trial page.